Other vaccine makers that have signed deals to receive US government funding for their efforts include Moderna Inc, AstraZeneca Plc and Novavax Inc.
其他已签署协议接受美国政府资助的疫苗生产商包括Moderna、阿斯利康和Novavax.。
Pfizer said it will deliver the doses if the product receives emergency use authorization or US approval as early as October after demonstrating safety and efficacy in a large Phase III clinical trial involving up to 30,000 subjects.
辉瑞公司表示,如果该产品在涉及3万名受试者的大型三期临床试验中证明其安全性和有效性,将最早在10月份获得紧急使用许可或美国批准,并提供疫苗产品。
Pfizer and BioNTech currently expect to manufacture up to 100 million doses globally by the end of 2020, and potentially more than 1.3 billion doses by the end of 2021, subject to final dose selection from their clinical trial.
预计到2020年底,辉瑞公司和BioNTech公司将可生产1亿剂疫苗,到2021年底可能生产超过13亿剂,这取决于临床试验的最终剂量选择。
On Monday, the companies agreed to supply the United Kingdom with 30 million doses of the vaccine candidate, but did not disclose a price.
周一,两家公司同意向英国供应3000万剂候选疫苗,但没有透露价格。
Pfizer shares were up nearly 5%, while BioNTech’s US-listed shares were up 13%.
【美国斥资近20亿美元签上亿剂疫苗合同】相关文章:
★ 撒掉的布朗尼蛋糕
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15